The trademark LUCIAD was filed by Teva Pharmaceutical Industries Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on July 8, 2021, and received one opposition filed on October 7, 2021 by Genentech, Inc. on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 7, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and address of the trademark registration was recorded on January 3, 2022.